Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for sleep disturbance during methamphetamine withdrawal
IRCT20181218042036N1Phase 4Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of modafinil in methamphetamine use disorder (MUD) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: sleep pattern, methamphetamine withdrawal and 1 more. Started Sep 2018; status: completed.
02
Drugs
modafinil
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on IRCT20181218042036N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181218042036N1.